arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

BioCorRx Inc.

BICX
— Price unavailable
Industrials ·Services-Specialty Outpatient Facilities, NEC ·USServices-Specialty Outpatient Facilities, NEC
70 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
41
Health
Weak
Neutral
auto_awesome

Analytical Summary

BioCorRx Inc. shows mixed fundamentals. Consider comparing against peers in the Industrials sector before making investment decisions.

Market Cap —
Dividend Yield —
Revenue Growth -50.6% ↘
Op. Margin None
ROIC 12.0% ↗
FCF / Share None
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close.

70-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$87.97K
↓ -50.6% —
Net Income Profit after all expenses
$-964.77K
↑ +21.8% —
Operating Margin Operating profit as % of sales
-445.6%
↓ -45.5% —
FCF / Share Free cash flow per share
$-0.02
↓ -2970.2% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
0
Returns ↓
93
Financial Health ↑
24
Cash Quality →
47

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 70 quarters